Glutamate Receptor 3 anticorps (AA 151-250)

N° du produit ABIN7153961

Cet anticorps Lapin Polyclonal détecte spécifiquement Glutamate Receptor 3 dans ELISA, IHC et IF. Il présente une réactivité envers Humain.

Aperçu rapide pour Glutamate Receptor 3 anticorps (AA 151-250) (ABIN7153961)

Antigène: Glutamate Receptor 3 (GRIA3) (Glutamate Receptor, Ionotropic, AMPA 3 (GRIA3))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Glutamate Receptor 3 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-Glutamate Receptor 3 anticorps

Épitope: AA 151-250

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Glutamate receptor 3 protein (151-250AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur Glutamate Receptor 3

Antigène: Glutamate Receptor 3 (GRIA3) (Glutamate Receptor, Ionotropic, AMPA 3 (GRIA3))

Autre désignation: GRIA3

Sujet:

Background: Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.

Aliases: AMPA 3 antibody, AMPA selective glutamate receptor 3 antibody, AMPA-selective glutamate receptor 3 antibody, dJ1171F9.1 antibody, GluA3 antibody, GLUK3 antibody, GluR 3 antibody, GLUR C antibody, GLUR K3 antibody, GluR-3 antibody, GluR-C antibody, GluR-K3 antibody, GLUR3 antibody, GLURC antibody, Glutamate ionotropic receptor AMPA type subunit 3 antibody, Glutamate receptor 3 antibody, Glutamate receptor C antibody, Glutamate receptor ionotrophic AMPA 3 antibody, Glutamate receptor ionotropic antibody, Glutamate receptor subunit 3 antibody, Glutamate receptor, ionotropic, AMPA 3 antibody, GRIA 3 antibody, Gria3 antibody, GRIA3_HUMAN antibody, Ionotrophic Glutamate Receptor antibody, MRX94 antibody

UniProt: P42263

Pathways: Signalisation PI3K-Akt, cAMP Metabolic Process, Synaptic Membrane